Equity Research, Broker Reports, and media content on MEDIVIR AB-B SHS

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MEDIVIR AB-B SHS
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MEDIVIR AB-B SHS. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
15Dec16 12:13 PRN Medivir Completes the Divestment of BioPhausia - a Transfer of Approx. SEK 870m to the Shareholders Through a Share Redemption Offer will be Proposed
14Dec16 01:46 PRN Medivir's fusion inhibitor for the treatment of Respiratory Syncytial Virus infection, MIV-323, enters non-clinical development
08Dec16 07:44 PRN MIV-711 Osteoarthritis Trial: Successful Third Independent Review of Safety Data and Trial Continues Without any Modifications
  • Frequency of research reports


  • Research reports on


  • Providers covering